首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning
【24h】

The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning

机译:恶唑烷酮抗生素干扰核糖体肽基转移酶中心并影响tRNA定位

获取原文
获取原文并翻译 | 示例
       

摘要

The oxazolidinones represent the first new class of antibiotics to enter into clinical usage within the past 30 years, but their binding site and mechanism of action has not been fully characterized. We have determined the crystal structure of the oxazolidinone lin-ezolid bound to the Deinococcus radiodurans 50S ribosomal sub-unit. Linezolid binds in the A site pocket at the peptidyltransferase center of the ribosome overlapping the aminoacyl moiety of an A-site bound tRNA as well as many clinically important antibiotics. Binding of linezolid stabilizes a distinct conformation of the universally conserved 23S rRNA nucleotide U2585 that would be nonproductive for peptide bond formation. In conjunction with available biochemical data, we present a model whereby oxazolidinones impart their inhibitory effect by perturbing the correct positioning of tRNAs on the ribosome.
机译:恶唑烷酮类是过去30年来进入临床使用的第一类新型抗生素,但其结合位点和作用机理尚未得到充分表征。我们已经确定了恶唑烷酮lin-ezolid结合到Deinococcus radiodurans 50S核糖体亚基的晶体结构。利奈唑胺在核糖体的肽基转移酶中心的A位点口袋中结合,与A位点结合的tRNA的氨酰基部分以及许多临床上重要的抗生素重叠。利奈唑胺的结合稳定了普遍保守的23S rRNA核苷酸U2585的独特构象,该构象对肽键的形成无用。结合可获得的生化数据,我们提出了一种模型,其中恶唑烷酮通过干扰tRNA在核糖体上的正确定位来赋予其抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号